HB 1346 (2020): requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 1346 (2020): requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders.” Granite Record, https://graniterecord.org/bill/2020/hb1346. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 1346 (2020): requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1346
Chicago
Granite Record. “HB 1346 (2020): requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1346.
BibTeX
@misc{bill-2020-hb1346, title = {HB 1346 (2020): requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1346}, note = {Accessed 24 Oct. 2026} }

HB 1346 (2020)

requiring the insurance department to make a report regarding the impact of insurance coverage for pediatric autoimmune neuropsychiatric disorders.

  • Status: Died on the table
  • Term: 2019-2020
  • House committee: Commerce and Consumer Affairs
  • Subject: Insurance

The Story

It was introduced on January 8, 2020 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 21, 2020. The committee held a work session on February 3, 2020. The committee met in executive session on February 4, 2020 to vote on its recommendation. The committee voted unanimously, 20–0, to recommend that the House pass it with changes (amendment 2020-0413h), and the report was placed on the consent calendar. The committee's amendment (2020-0413h) was adopted on a voice vote on March 11, 2020, changing the text of the bill. On March 11, 2020 the House voted to pass it with changes on a voice vote. On June 16, 2020 the Senate adopted “Introduced 06/16/2020, and Laid on Table” on a voice vote. The bill died on the table under Senate Rule 3-23 at adjournment on September 16, 2020, having been set aside and never taken back up.

Sponsors

Hearings and Sessions

  • January 21, 2020, 1:45 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
  • February 3, 2020, 1:00 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • February 4, 2020, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302

Votes

  • March 11, 2020, House: Ought to Pass with Amendment 2020-0413h — voice vote, passed
  • June 16, 2020, Senate: Introduced 06/16/2020, and Laid on Table — voice vote, passed

The Docket

  • January 8, 2020: Introduced 01/08/2020 and referred to Commerce and Consumer Affairs
  • January 21, 2020: Public Hearing: 01/21/2020 01:45 pm LOB 302
  • February 3, 2020: Subcommittee Work Session: 02/03/2020 01:00 pm LOB 302
  • February 4, 2020: Executive Session: 02/04/2020 10:00 am LOB 302
  • March 11, 2020: Committee Report: Ought to Pass with Amendment #2020-0413h for 03/11/2020 (Vote 20-0; CC)
  • March 11, 2020: Amendment #2020-0413h : AA VV 03/11/2020
  • March 11, 2020: Ought to Pass with Amendment 2020-0413h: MA VV 03/11/2020
  • June 16, 2020: Introduced 06/16/2020, and Laid on Table, MA, VV; 06/16/2020
  • September 16, 2020: Inexpedient to Legislate, Senate Rule 3-23, Adjournment 09/16/2020

From the General Court